Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
||||||
GSE135550 |
MLL4 establishes enhancer-associated condensates to counterbalance Polycomb-mediated nuclear mechanical stress in Kabuki Syndrome [3'UTR RNA-seq]
|
12 | CIBIO Zippo | Sep 09, 2020 | ||||
GSE137207 |
Pattern occupation of HDACs on chromatin determines PI3K/AKT inhibitor resistance in cancers [ChIP-seq]
|
18 | Zhenqing Ye | Sep 09, 2020 | ||||
GSE137209 |
Bromodomain and HDAC inhibitors equivalently suppress PI3K/AKT inhibition resistance in cancers
|
56 |
|
Zhenqing Ye | Sep 09, 2020 | |||
GSE138436 |
Epigenetic gene silencing by heterochromatin primes fungal resistance
|
49 | Sito Torres-Garcia | Sep 09, 2020 | ||||
GSE139253 |
Visualization and Sequencing of Accessible Chromatin Reveals Cell Cycle and Post-HDAC inhibitor Treatment Dynamics
|
26 | Sriharsa Pradhan | Sep 09, 2020 | ||||
GSE141185 |
H1 linker histones regulate the balance of repressive and active chromatin domains via localized genomic compaction [ChIP-seq]
|
12 | Boris Bartholdy | Sep 09, 2020 | ||||
GSE142589 |
m6A RNA methyltransferases Mettl3/14 regulate immune responses to anti-PD-1 therapy
|
27 | Lingling Wang | Sep 09, 2020 | ||||
GSE147455 |
An epigenetic vulnerability in PI3K/AKT inhibition resistant cancers is targetable by both bromodomain and HDAC inhibitors
|
32 | Zhenqing Ye | Sep 09, 2020 | ||||
GSE156500 |
Chidamide used in MM cell line [ChIP-seq]
|
4 | Yifeng Sun | Sep 09, 2020 | ||||
GSE156502 |
Chidamide effect on MM
|
10 | Yifeng Sun | Sep 09, 2020 |